The Role of Metabolic Parameters in FDG PET-CT Imaging for Predicting Progression-Free Survival in Radioiodine Refractory Thyroid Cancer: A Single-Center Study

被引：0
|
作者：
Khatami, Alireza [1 ]
Sutherland, Duncan [2 ]
机构：
[1] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada
[2] Univ Western Ontario, London Hlth Sci Ctr, London, ON, Canada
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
242421
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Prospective evaluation of qualitative and quantitative 18F-FDG PET-CT parameters for predicting progression free survival and overall survival in recurrent carcinoma cervix
    Sharma, P.
    Maharjan, S.
    Patel, C.
    Sharma, D. N.
    Malhotra, A.
    Dhull, V. S.
    Kumar, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S269 - S269
  • [12] Early metabolic responses on FDG PET-CT in 7 days correlate with progression-free survival (PFS) in patients with metastatic melanomas after initiation of targeted therapy
    Wong, Franklin
    Chen, Su Yun
    Woodman, Scott
    Kim, Kevin
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [13] Is F-18-FDG-PET/CT usefull to stage or predict progression-free survival in breast cancer patients?
    Sollini, M.
    Zangheri, B.
    Calabrese, L.
    Di Paolo, M. L.
    Versari, A.
    Gasparini, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S267 - S268
  • [14] The effect of statins on overall survival and progression-free survival in veterans with prostate cancer: A retrospective single-center experience.
    Warnecke, Brian
    Djoumessi, Djoufack Raissa Lakene
    Garza, Juan
    Mader, Michael
    Chaudhary, Shreya
    Datta, Paromita
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [15] Germline HRR Mutations in Metastatic NSCLC and Impact on Progression-Free Survival: A Single-Center Retrospective Study
    Vakkalagadda, C.
    Bucheit, L.
    Sun, Z.
    Kocherginsky, M.
    Chae, Y. K.
    Boumber, Y.
    Mohindra, N. A.
    Patel, J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S410 - S410
  • [16] The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: A prospective single-center study
    Baldazzi, Valentina
    Tassi, Renato
    Lapini, Alberto
    Santomaggio, Carmine
    Carini, Marco
    Mazzanti, Roberto
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (05) : 704 - 710
  • [17] Association of FDG PET-CT (PET) avid skeletal lesions (SL) with progression-free survival (PFS) in patients (pts) with previously untreated follicular lymphoma (FL).
    Maly, Joseph J.
    Wei, Lai
    Hemminger, Jessica
    Christian, Beth
    Maddocks, Kami J.
    Jones, Jeffrey Alan
    Wright, Chad
    Blum, Kristie A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [18] Tenosynovial Giant Cell Tumor of Foot in a Patient with Radioiodine-Refractory Thyroid Cancer: Imaging Findings on FDG-PET/CT, MRI, and Radioiodine Scan
    Loharkar, Sarvesh
    Basu, Sandip
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2023, 22 (01) : 63 - 66
  • [19] Radiomics Analysis of PET and CT Components of 18F-FDG PET/CT Imaging for Prediction of Progression-Free Survival in Advanced High-Grade Serous Ovarian Cancer
    Wang, Xihai
    Lu, Zaiming
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [20] Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei
    Hotta, Masatoshi
    Minamimoto, Ryogo
    Gohda, Yoshimasa
    Igari, Toru
    Yano, Hideaki
    EUROPEAN RADIOLOGY, 2019, 29 (10) : 5709 - 5716
12345